BPC-157 and TB-500 Dosage Protocol BPC-157: 250500mcg daily, injected subcutaneously near the injury site TB-500: 22.5mg twice weekly (loading phase) for 46 weeks, then 2mg once weekly (maintenance phase) The combination is typically used for 612 weeks, depending on injury severity and healing progress
it initiates repair pathways that persist long after the peptide is metabolized
Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route
Any athlete in WADA-tested competition who tests positive for either peptide faces a sanction regardless of formulation or intent
Male SpragueDawley (SD) rats weighing 200 20 g were obtained from the Animal Experiment Center of the Fourth Military Medical University (Xian, China) and housed in a specific pathogen-free animal facility
5-amino-1mq 5-amino-1mq from the Nexus Mitochondrial & Energy catalog, supplied for controlled in-vitro research workflows